FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198382015> ?p ?o ?g. }

• W3198382015 endingPage "8745" @default.
• W3198382015 startingPage "8741" @default.
• W3198382015 abstract "Abstract Androgen deprivation therapy (ADT), also known as suppression of androgen activity, is a first‐line treatment option for patients with prostate cancer (PC). ADT became ineffective after several years of treatment due to the development of castration‐resistant prostate cancer (CRPC), which resulted in more deaths in PC patients, but it is still androgen receptor (AR) dependent. Under these conditions, the U.S. Food and Drug Administration (FDA) approved enzalutamide for the treatment of patients with metastatic CRPC (mCRPC) and, more recently, nonmetastatic CRPC (nmCRPC). Despite the fact that this drug has extended overall and progression‐free survival in a wide range of CRPC patients, more research is needed to better understand the mechanisms of resistance challenges and analogues chemical lead structures as next generation AR antagonists. In this regard, we discovered simple and easily synthesizable new pharmacophore, 4,4 ‐dimethylimidazolidin‐2‐one, based derivatives MDV1‐MDV8 for potent AR antagonists; here, the thiohydantoin pharmacophore in enzalutamide is replaced by 4,4‐dimethylimidazolidin‐2‐one. The antiproliferative activities of these molecules have been assessed against androgen dependent PC cell line (LNCaP). The structure‐activity relationship of these molecules, as well as their relationship with enzalutamide, is investigated. Among the reported molecules, MDV4 showed significantly improved in vitro activity with the IC 50 value of 780.85 nM." @default.
• W3198382015 created "2021-09-13" @default.
• W3198382015 creator A5000377332 @default.
• W3198382015 creator A5005192042 @default.
• W3198382015 creator A5010146342 @default.
• W3198382015 creator A5012485378 @default.
• W3198382015 creator A5016687706 @default.
• W3198382015 creator A5028682139 @default.
• W3198382015 creator A5046428703 @default.
• W3198382015 creator A5080508837 @default.
• W3198382015 date "2021-09-02" @default.
• W3198382015 modified "2023-10-17" @default.
• W3198382015 title "Discovery of Easily Synthesizable 4, 4‐Dimethylimidazolidin‐2‐ones as Potent Androgen Receptor Antagonists for Prostate Cancer" @default.
• W3198382015 cites W1968786809 @default.
• W3198382015 cites W2004732836 @default.
• W3198382015 cites W2005958584 @default.
• W3198382015 cites W2014476883 @default.
• W3198382015 cites W2043729296 @default.
• W3198382015 cites W2054422997 @default.
• W3198382015 cites W2058818042 @default.
• W3198382015 cites W2070893243 @default.
• W3198382015 cites W2082107721 @default.
• W3198382015 cites W2085612296 @default.
• W3198382015 cites W2107798431 @default.
• W3198382015 cites W2117857186 @default.
• W3198382015 cites W2121846636 @default.
• W3198382015 cites W2130189600 @default.
• W3198382015 cites W2335455445 @default.
• W3198382015 cites W2481479138 @default.
• W3198382015 cites W2554750936 @default.
• W3198382015 cites W2586987557 @default.
• W3198382015 cites W2750934051 @default.
• W3198382015 cites W2808687910 @default.
• W3198382015 cites W2889646458 @default.
• W3198382015 cites W2895926103 @default.
• W3198382015 cites W2911362138 @default.
• W3198382015 cites W2917837889 @default.
• W3198382015 cites W2918963306 @default.
• W3198382015 cites W2921176969 @default.
• W3198382015 cites W2943609335 @default.
• W3198382015 cites W3112701574 @default.
• W3198382015 cites W608773482 @default.
• W3198382015 doi "https://doi.org/10.1002/slct.202101546" @default.
• W3198382015 hasPublicationYear "2021" @default.
• W3198382015 type Work @default.
• W3198382015 sameAs 3198382015 @default.
• W3198382015 citedByCount "1" @default.
• W3198382015 countsByYear W31983820152022 @default.
• W3198382015 crossrefType "journal-article" @default.
• W3198382015 hasAuthorship W3198382015A5000377332 @default.
• W3198382015 hasAuthorship W3198382015A5005192042 @default.
• W3198382015 hasAuthorship W3198382015A5010146342 @default.
• W3198382015 hasAuthorship W3198382015A5012485378 @default.
• W3198382015 hasAuthorship W3198382015A5016687706 @default.
• W3198382015 hasAuthorship W3198382015A5028682139 @default.
• W3198382015 hasAuthorship W3198382015A5046428703 @default.
• W3198382015 hasAuthorship W3198382015A5080508837 @default.
• W3198382015 hasConcept C121608353 @default.
• W3198382015 hasConcept C126322002 @default.
• W3198382015 hasConcept C143998085 @default.
• W3198382015 hasConcept C2776551883 @default.
• W3198382015 hasConcept C2777899217 @default.
• W3198382015 hasConcept C2777911890 @default.
• W3198382015 hasConcept C2779723316 @default.
• W3198382015 hasConcept C2780035454 @default.
• W3198382015 hasConcept C2780192828 @default.
• W3198382015 hasConcept C2780962315 @default.
• W3198382015 hasConcept C502942594 @default.
• W3198382015 hasConcept C56173144 @default.
• W3198382015 hasConcept C60644358 @default.
• W3198382015 hasConcept C61367390 @default.
• W3198382015 hasConcept C71315377 @default.
• W3198382015 hasConcept C71924100 @default.
• W3198382015 hasConcept C86803240 @default.
• W3198382015 hasConcept C98274493 @default.
• W3198382015 hasConceptScore W3198382015C121608353 @default.
• W3198382015 hasConceptScore W3198382015C126322002 @default.
• W3198382015 hasConceptScore W3198382015C143998085 @default.
• W3198382015 hasConceptScore W3198382015C2776551883 @default.
• W3198382015 hasConceptScore W3198382015C2777899217 @default.
• W3198382015 hasConceptScore W3198382015C2777911890 @default.
• W3198382015 hasConceptScore W3198382015C2779723316 @default.
• W3198382015 hasConceptScore W3198382015C2780035454 @default.
• W3198382015 hasConceptScore W3198382015C2780192828 @default.
• W3198382015 hasConceptScore W3198382015C2780962315 @default.
• W3198382015 hasConceptScore W3198382015C502942594 @default.
• W3198382015 hasConceptScore W3198382015C56173144 @default.
• W3198382015 hasConceptScore W3198382015C60644358 @default.
• W3198382015 hasConceptScore W3198382015C61367390 @default.
• W3198382015 hasConceptScore W3198382015C71315377 @default.
• W3198382015 hasConceptScore W3198382015C71924100 @default.
• W3198382015 hasConceptScore W3198382015C86803240 @default.
• W3198382015 hasConceptScore W3198382015C98274493 @default.
• W3198382015 hasIssue "33" @default.
• W3198382015 hasLocation W31983820151 @default.
• W3198382015 hasOpenAccess W3198382015 @default.
• W3198382015 hasPrimaryLocation W31983820151 @default.
• W3198382015 hasRelatedWork W2063882679 @default.

• next